Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women’s Health Initiative Study

Pancreatic cancer is the fourth leading cause of cancer death. Soluble receptor for glycation end products (sRAGE), which is modulated by anti-hypertensive (HT) medications, has been inversely associated with pancreatic cancer. However, the association between commonly used anti-HT medications and r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Med
Päätekijät: Wang, Zhensheng, White, Donna L., Hoogeveen, Ron, Chen, Liang, Whitsel, Eric A., Richardson, Peter A., Virani, Salim S., Garcia, Jose M., El-Serag, Hashem B., Jiao, Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6111748/
https://ncbi.nlm.nih.gov/pubmed/30072610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7080197
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia